JYSB2300075 | 甲氧聚二醇重组人促红素注射液 | | Injection | Biological Products | Supplementary Application | 2023-04-26 | | | | | view |
JYSB2200127 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2022-07-14 | | | | | view |
CXSL2200530 | 长效重组人促红素注射液 | | Injection | Biological Products(3.3) | New Drug Application | 2022-10-20 | | NCPC Genetech BIOTECHNOLOGY Co Ltd | | | view |
CYSB2101012 | 重组人促红素注射液(CHO细胞) | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2021-03-22 | | Beijing Four Rings Bio-Pharmaceutical Co Ltd | | | view |
JXSL1000030 | 甲氧聚二醇重组人促红素注射液 | | Injection | Biological Products | Import Drug Application | 2010-08-04 | | Roche Pharma (Schweiz) Ltd | Certificate Issued | 2013-02-19 | view |
CYSB2400127 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products(3.4) | Supplementary Application | 2024-05-22 | | | | | view |
CYSB2200076 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2022-03-10 | | Kexing Biopharm Co Ltd | | | view |
JXSS1300006 | 甲氧聚二醇重组人促红素注射液 | | Injection | Biological Products | Import Drug Application | 2013-06-18 | | | Certificate Issued | 2018-05-24 | view |
CYSB2101255 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2021-11-04 | | NCPC Genetech BIOTECHNOLOGY Co Ltd | | | view |
CYSB2400205 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2024-08-08 | | NCPC Genetech BIOTECHNOLOGY Co Ltd | | | view |
JYSB2200152 | 甲氧聚二醇重组人促红素注射液 | | Injection | Biological Products | Supplementary Application | 2022-08-12 | | | | | view |
CYSB2400201 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2024-08-08 | | NCPC Genetech BIOTECHNOLOGY Co Ltd | | | view |
CXSB2300011 | 聚乙二醇重组人促红素注射液 | | Injection | Biological Products(1) | Supplementary Application | 2023-02-03 | | Shenzhen Sciprogen Bio-pharmaceutical Co Ltd | | | view |
CXSL2200533 | 长效重组人促红素注射液 | | Injection | Biological Products(3.3) | New Drug Application | 2022-10-20 | | NCPC Genetech BIOTECHNOLOGY Co Ltd | | | view |
JYSZ2200043 | 甲氧聚二醇重组人促红素注射液 | | Injection | Biological Products | License Renew | 2022-08-30 | | | | | view |
CYSB2101008 | 重组人促红素注射液(CHO细胞) | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2021-03-22 | | Beijing Four Rings Bio-Pharmaceutical Co Ltd | | | view |
JXSL1000034 | 甲氧聚二醇重组人促红素注射液 | | Injection | Biological Products | Import Drug Application | 2010-08-04 | | Roche Pharma (Schweiz) Ltd | Certificate Issued | 2013-02-19 | view |
CYSB2400066 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2024-03-09 | | | | | view |
JYSB2200153 | 甲氧聚二醇重组人促红素注射液 | | Injection | Biological Products | Supplementary Application | 2022-08-12 | | | | | view |
CYSB2200214 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2022-08-26 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |